Alivus Life Sciences Financials
NSE: GLS | BSE: 543322
₹1,360.80
As on 26-Aug-2026IST
Market cap
₹16,697 Cr
Revenue (TTM)
₹2,590 Cr
P/E Ratio
27.7
P/B Ratio
4.8
Div. Yield
0.4 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,590.40
|
2,551.83
|
2,386.88
|
2,283.21
|
2,161.22
|
2,123.21
|
|||||
|
Total Income
|
2,664.23
|
2,612.24
|
2,421.45
|
2,295.26
|
2,190.18
|
2,137.92
|
|||||
|
Total Expenditure
|
1,753.71
|
1,754.55
|
1,704.30
|
1,608.97
|
1,518.93
|
1,507.15
|
|||||
|
EBITDA
|
836.69
|
797.28
|
682.58
|
674.25
|
642.29
|
616.06
|
|||||
|
Depreciation
|
78.88
|
75.36
|
60.61
|
53.45
|
42.09
|
37.88
|
|||||
|
EBIT
|
757.81
|
721.93
|
621.98
|
620.79
|
600.20
|
578.18
|
|||||
|
Interest
|
5.43
|
5.37
|
2.41
|
1.55
|
0.55
|
27.96
|
|||||
|
Other Income
|
73.83
|
60.41
|
34.57
|
12.04
|
28.96
|
14.70
|
|||||
|
Exceptional Items
|
-25.66
|
-25.66
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
800.55
|
751.31
|
654.13
|
631.29
|
628.61
|
564.93
|
|||||
|
Provision for Tax
|
197.53
|
186.83
|
168.50
|
160.40
|
161.65
|
146.20
|
|||||
|
Profit after Tax
|
603.02
|
564.48
|
485.63
|
470.89
|
466.96
|
418.72
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,332.13
|
3,332.13
|
2,817.37
|
2,332.32
|
2,138.21
|
2,054.31
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
142.73
|
142.73
|
466.05
|
756.95
|
67.40
|
32.70
|
|||||
|
Current Liabilities
|
508.04
|
682.24
|
470.16
|
438.77
|
1,014.89
|
746.80
|
|||||
|
Total Liabilities
|
3,982.90
|
4,157.10
|
3,753.59
|
3,528.05
|
3,220.49
|
2,833.81
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,321.38
|
1,333.54
|
1,418.43
|
1,612.05
|
851.81
|
706.42
|
|||||
|
Current Assets
|
2,649.36
|
2,823.56
|
2,335.16
|
1,916.00
|
2,368.68
|
2,127.39
|
|||||
|
Total Assets
|
3,982.90
|
4,157.10
|
3,753.59
|
3,528.05
|
3,220.49
|
2,833.81
|
|||||
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Current Assets
|
2,141.33
|
2,141.33
|
1,865.00
|
1,477.23
|
1,353.80
|
1,380.59
|
|||||
|
Contingent Liabilities
|
--
|
4.82
|
4.82
|
4.82
|
2.22
|
2.22
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
565.41
|
391.52
|
413.52
|
306.01
|
597.59
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-570.15
|
-615.65
|
-116.48
|
-146.75
|
-122.23
|
|||||
|
Cash from Financing Activities
|
--
|
-64.34
|
-6.23
|
-279.44
|
-387.59
|
-78.80
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-69.08
|
-230.35
|
17.59
|
-228.33
|
396.56
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
50.73
|
45.99
|
39.63
|
38.43
|
38.11
|
34.17
|
|||||
|
Cash EPS (₹)
|
49.12
|
52.13
|
44.58
|
42.79
|
41.55
|
37.27
|
|||||
|
Adjusted Book Value (₹)
|
283.86
|
270.90
|
229.11
|
189.45
|
173.97
|
167.38
|
|||||
|
Dividend per Share (₹)
|
0.37
|
5.00
|
5.00
|
22.50
|
21.00
|
21.00
|
|||||
|
Cash Flow per Share (₹)
|
--
|
46.07
|
31.95
|
33.75
|
24.98
|
48.77
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
16.64
|
16.30
|
21.33
|
10.82
|
34.63
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
24.61
|
25.50
|
28.31
|
30.01
|
42.24
|
|||||
|
ROE (%)
|
19.61
|
18.41
|
18.94
|
21.15
|
22.33
|
29.87
|
|||||
|
ROA (%)
|
16.31
|
14.27
|
13.34
|
13.96
|
15.43
|
16.57
|
|||||
|
EBIT Margin (%)
|
29.25
|
28.29
|
26.06
|
27.19
|
27.77
|
27.23
|
|||||
|
Net Margin (%)
|
22.63
|
21.61
|
20.06
|
20.52
|
21.32
|
19.59
|
|||||
|
Cash Profit Margin (%)
|
--
|
24.81
|
22.79
|
22.90
|
23.43
|
21.48
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
7.93
|
6.91
|
4.54
|
5.64
|
1.79
|
12.63
|
|||||
|
EBIT Growth (%)
|
19.88
|
16.07
|
0.19
|
3.43
|
3.81
|
3.68
|
|||||
|
Net Profit Growth (%)
|
25.58
|
16.24
|
3.13
|
0.84
|
11.52
|
19.10
|
|||||
|
EPS Growth (%)
|
21.50
|
16.05
|
3.12
|
0.84
|
11.52
|
4.78
|
|||||
|
Book Value Growth (%)
|
--
|
18.43
|
20.94
|
8.90
|
3.94
|
172.44
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
27.69
|
21.18
|
27.24
|
20.17
|
10.28
|
13.43
|
|||||
|
Price / Book Value
|
4.79
|
3.60
|
4.71
|
4.09
|
2.25
|
2.74
|
|||||
|
Dividend Yield (%)
|
0.37
|
0.51
|
0.46
|
2.90
|
5.36
|
4.58
|
|||||
|
EV/EBITDA
|
18.34
|
13.94
|
18.35
|
13.40
|
6.69
|
8.10
|
|||||
|
Close Price (₹)
|
1,156.50
|
972.70
|
1,081.15
|
776.65
|
392.90
|
458.80
|
|||||
|
High Price (₹)
|
1,176.90
|
1,225.10
|
1,335.10
|
906.00
|
534.00
|
799.95
|
|||||
|
Low Price (₹)
|
819.00
|
819.00
|
743.60
|
375.95
|
369.00
|
376.00
|
|||||
|
Market Cap (₹ Cr)
|
16,696.92
|
11,956.86
|
13,228.83
|
9,499.31
|
4,798.12
|
5,623.90
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
5.21
|
4.14
|
4.97
|
4.37
|
2.33
|
2.85
|
|||||
|
Quick Ratio
|
3.85
|
3.12
|
3.53
|
2.85
|
1.74
|
2.16
|
|||||
|
Interest Coverage
|
148.49
|
140.86
|
271.97
|
409.34
|
1,150.19
|
21.20
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
41.42
|
42.05
|
40.63
|
33.52
|
37.33
|
31.72
|
|||||
|
Asset Turnover
|
0.70
|
0.65
|
0.66
|
0.68
|
0.72
|
0.84
|
|||||
|
Receivable days
|
--
|
144.58
|
132.12
|
125.30
|
124.34
|
111.01
|
|||||
|
Inventory Days
|
--
|
96.67
|
102.08
|
101.28
|
94.11
|
88.40
|
|||||
|
Payable days
|
--
|
135.45
|
133.54
|
149.95
|
136.29
|
94.72
|
|||||
|
Cash Conversion Cycle
|
--
|
105.80
|
100.66
|
76.63
|
82.16
|
104.69
|